Pharmaceutical Toxicology is the Most Important Component of Preclinical Studies

The first principle for ensuring patient safety is to do no harm (primum non nocere). It clearly justifies why the legislative requirements of medicinal products should be strict and meticulous. aim preclinical evaluation protect public health by preventing clinical use with a potentially unfavourable risk–benefit profile. Traditionally, toxicology defined as study adverse effects chemical substances on living organisms. Toxicity studies are integral programmes new products. role in explained this interview Corresponding Member Russian Academy Sciences, Doctor Medical Full Professor Andrey D. Durnev. Dr. Durnev laureate State Prize Federation. He holds positions Head Pharmaceutical Toxicology Department V.V. Zakusov Institute Pharmacology, Chairman Commission Ministry Health Federation Certification Experts Right Perform Regulatory Evaluation Medicinal Products Human Use, Deputy Interdepartmental Council Sciences Scientific Substantiation Maintenance Drug Policy